X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Divis Laboratories with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs JUBILANT LIFE SCIENCES - Comparison Results

DIVIS LABORATORIES    Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES JUBILANT LIFE SCIENCES DIVIS LABORATORIES/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 18.1 20.1 90.3% View Chart
P/BV x 3.9 4.3 91.9% View Chart
Dividend Yield % 1.6 0.4 370.3%  

Financials

 DIVIS LABORATORIES   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-16
JUBILANT LIFE SCIENCES
Mar-14
DIVIS LABORATORIES/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs2,484187 1,329.6%   
Low Rs91865 1,410.3%   
Sales per share (Unadj.) Rs142.3364.3 39.0%  
Earnings per share (Unadj.) Rs41.96.8 611.8%  
Cash flow per share (Unadj.) Rs46.324.5 189.1%  
Dividends per share (Unadj.) Rs10.003.00 333.3%  
Dividend yield (eoy) %0.62.4 24.7%  
Book value per share (Unadj.) Rs161.5164.9 97.9%  
Shares outstanding (eoy) m265.47159.28 166.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x12.00.3 3,458.8%   
Avg P/E ratio x40.618.4 220.7%  
P/CF ratio (eoy) x36.75.1 714.0%  
Price / Book Value ratio x10.50.8 1,378.7%  
Dividend payout %23.943.8 54.5%   
Avg Mkt Cap Rs m451,52520,061 2,250.7%   
No. of employees `0003.76.2 60.0%   
Total wages/salary Rs m3,64911,052 33.0%   
Avg. sales/employee Rs Th10,184.49,383.0 108.5%   
Avg. wages/employee Rs Th984.11,786.9 55.1%   
Avg. net profit/employee Rs Th2,998.5176.3 1,700.8%   
INCOME DATA
Net Sales Rs m37,76458,034 65.1%  
Other income Rs m848191 445.1%   
Total revenues Rs m38,61258,224 66.3%   
Gross profit Rs m14,1385,786 244.3%  
Depreciation Rs m1,1822,812 42.0%   
Interest Rs m233,237 0.7%   
Profit before tax Rs m13,781-72 -19,113.6%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m2,662696 382.3%   
Profit after tax Rs m11,1191,090 1,019.7%  
Gross profit margin %37.410.0 375.5%  
Effective tax rate %19.3-965.9 -2.0%   
Net profit margin %29.41.9 1,567.0%  
BALANCE SHEET DATA
Current assets Rs m30,94729,280 105.7%   
Current liabilities Rs m5,19538,912 13.4%   
Net working cap to sales %68.2-16.6 -410.9%  
Current ratio x6.00.8 791.6%  
Inventory Days Days11784 138.4%  
Debtors Days Days8551 168.0%  
Net fixed assets Rs m17,02755,712 30.6%   
Share capital Rs m531155 343.6%   
"Free" reserves Rs m42,34120,968 201.9%   
Net worth Rs m42,87726,265 163.2%   
Long term debt Rs m517,169 0.0%   
Total assets Rs m49,68488,606 56.1%  
Interest coverage x595.01.0 60,855.8%   
Debt to equity ratio x00.7 0.0%  
Sales to assets ratio x0.80.7 116.0%   
Return on assets %22.44.9 459.1%  
Return on equity %25.94.2 624.6%  
Return on capital %32.211.6 278.3%  
Exports to sales %85.337.8 225.6%   
Imports to sales %22.916.5 139.0%   
Exports (fob) Rs m32,19821,933 146.8%   
Imports (cif) Rs m8,6549,567 90.5%   
Fx inflow Rs m32,27022,004 146.7%   
Fx outflow Rs m8,77511,749 74.7%   
Net fx Rs m23,49610,255 229.1%   
CASH FLOW
From Operations Rs m10,3798,026 129.3%  
From Investments Rs m-4,135-1,744 237.1%  
From Financial Activity Rs m-6,241-4,447 140.3%  
Net Cashflow Rs m31,834 0.2%  

Share Holding

Indian Promoters % 52.0 45.6 114.0%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 11.8 8.7 135.6%  
FIIs % 19.0 21.2 89.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 21.1 81.5%  
Shareholders   31,796 23,815 133.5%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   FRESENIUS KABI ONCO.  AJANTA PHARMA  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare DIVIS LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Aug 18, 2017 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - SUN PHARMA COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS